The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.

By Jan Hoffman Seven months after the Supreme Court struck down a deal that would have resolved thousands of opioid cases against Purdue Pharma, the company’s owners, members of the Sackler ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

Purdue Pharma will pay more than $7 billion for the corporation's role in fueling the opioid epidemic that has killed hundreds of thousands of Americans. The Sackler family and Purdue Pharma reached a ...

Purdue Pharma’s owners from the Sackler family have struck a new $6.5 billion settlement of mass litigation alleging they fueled addiction, reopening a path to end the longest and costliest corporate ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

NSDUH only queried opioid misusers about opioid use disorder symptoms. After they changed the protocol and asked all ...

A number of counties are using opioid settlement money for child welfare purposes, but spending by Cameron County was ...

Purdue has sold a Narcan alternative since 2022 and Hikma has developed an opioid antagonist twice the dose of Narcan.

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

By Nadia Ramlagan Public News Service As opioid settlement money continues to flow into Kentucky, counties are having to make ...